---
title: 'Applying the ILAE diagnostic criteria for Lennox-Gastaut syndrome in the real-world
  setting: A multicentre retrospective cohort study'
date: '2023-12-23'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38135919/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231223170641&v=2.18.0
source: heidelberg[Affiliation]
description: 'OBJECTIVE: Lennox-Gastaut syndrome (LGS) is an archetypal developmental
  and epileptic encephalopathy, for which novel treatments are emerging. Diagnostic
  criteria for LGS have recently been defined by the International League Against
  Epilepsy (ILAE). We aimed to apply these criteria in the real-world ...'
disable_comments: true
---
OBJECTIVE: Lennox-Gastaut syndrome (LGS) is an archetypal developmental and epileptic encephalopathy, for which novel treatments are emerging. Diagnostic criteria for LGS have recently been defined by the International League Against Epilepsy (ILAE). We aimed to apply these criteria in the real-world ...